John R Stuelpnagel
Director at 10x Genomics, Inc. (TXG)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 8SEC | TXG10x Genomics, Inc. | Sell | 7,012341,424 held (−2%) | $60.66 | $425K | +33.0% |
| Sep 8SEC | TXG10x Genomics, Inc. | Sell | 6,814334,610 held (−2%) | $62.11 | $423K | +29.9% |
| Sep 8SEC | TXG10x Genomics, Inc. | Sell | 6,174328,436 held (−2%) | $62.61 | $387K | +28.8% |
| Aug 13SEC | TXG10x Genomics, Inc. | Sell | 17,000351,436 held (−5%) | $57.58 | $979K | +40.1% |
| Aug 13SEC | TXG10x Genomics, Inc. | Sell | 3,000348,436 held (−1%) | $58.73 | $176K | +37.3% |